Post-quantum cryptography standards highlight the need for governments to prepare for emerging quantum computing risks. Previously considered a distant concern, quantum computers may soon compromise the government’s most sensitive data. Here's how to get ready.
Peter Wilson, Public Sector Industry Architect at Pegasystems, discusses how the NHS can take inspiration from how private sector organisations are benefiting from digital transformation.
Speaking to UK politicians, Facebook whistleblower Frances Haugen suggests the Online Safety Bill should address "legal but harmful" content - the type that leads to self-harm.
David Chadwick, Crossword Cybersecurity, outlines how the W3C Verifiable Credentials standard works and why he believes it will become the de facto credentials mechanism for public sector services in the near future.
Digital transformation is the process of leveraging digitisation to transform business outcomes. So, what is the difference? Jason Chester, Director of Global Channel Programs, InfinityQS, explains here.
Leading tech experts offer their insight and advice around the evolving threat landscape, problems facing cybersecurity teams, and how companies can bolster cyber defences.
Adrian Overall, CEO and Founder of CloudStratex, discusses how the UK government has historically struggled to digitally transform itself and how it can be best be addressed to ensure value for the taxpayer.
Simon Gray, Head of Finance and Operations at Agilisys, discusses how modern agile financial management systems can enhance strategic decision making in the public sector.
Hugh Stevens, the Head of Strategic Growth at LiveRamp, explores how better data use can help ensure the high street can truly get back on its feet post-pandemic, the impact of eCommerce on the future of retail and how physical stores can survive.
The destruction of the Amazon rainforest influences how much carbon is released - now, scientists reveal that damaged, not-yet-destroyed areas are releasing carbon faster than the rainforest can store it.
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, discusses the experimental approaches towards Glycoscience and emphasises the need for collecting and integrating glyco-related information.
The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.
The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.
